Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

The prognostic value of the temporal course of S100beta protein in post-acute severe brain injury: A prospective and observational study.

Murillo-Cabezas F, Muñoz-Sánchez MA, Rincón-Ferrari MD, Martín-Rodríguez JF, Amaya-Villar R, García-Gómez S, León-Carrión J.

Brain Inj. 2010;24(4):609-19. doi: 10.3109/02699051003652823.

PMID:
20235763
2.

Effect of midazolam versus propofol sedation on markers of neurological injury and outcome after isolated severe head injury: a pilot study.

Ghori KA, Harmon DC, Elashaal A, Butler M, Walsh F, O'Sullivan MG, Shorten GD.

Crit Care Resusc. 2007 Jun;9(2):166-71.

PMID:
17536986
3.

Role of serum S100B as a predictive marker of fatal outcome following isolated severe head injury or multitrauma in males.

da Rocha AB, Schneider RF, de Freitas GR, André C, Grivicich I, Zanoni C, Fossá A, Gehrke JT, Pereira Jotz G, Kaufmann M, Simon D, Regner A.

Clin Chem Lab Med. 2006;44(10):1234-42.

PMID:
17032136
4.

[Can serum protein S100beta predict neurological deterioration after moderate or minor traumatic brain injury?].

Bouzat P, Francony G, Declety P, Brun J, Kaddour A, Renversez JC, Jacquot C, Payen JF.

Ann Fr Anesth Reanim. 2009 Feb;28(2):135-9. doi: 10.1016/j.annfar.2008.12.019. Epub 2009 Feb 10. French.

PMID:
19211218
5.

Neuron-specific enolase and S100BB as outcome predictors in severe diffuse axonal injury.

Chabok SY, Moghadam AD, Saneei Z, Amlashi FG, Leili EK, Amiri ZM.

J Trauma Acute Care Surg. 2012 Jun;72(6):1654-7. doi: 10.1097/TA.0b013e318246887e.

PMID:
22695436
6.

The usefulness of S100B, NSE, GFAP, NF-H, secretagogin and Hsp70 as a predictive biomarker of outcome in children with traumatic brain injury.

Žurek J, Fedora M.

Acta Neurochir (Wien). 2012 Jan;154(1):93-103; discussion 103. doi: 10.1007/s00701-011-1175-2.

PMID:
21976236
7.

Accuracy of the S100β protein as a marker of brain damage in traumatic brain injury.

Egea-Guerrero JJ, Revuelto-Rey J, Murillo-Cabezas F, Muñoz-Sánchez MA, Vilches-Arenas A, Sánchez-Linares P, Domínguez-Roldán JM, León-Carrión J.

Brain Inj. 2012;26(1):76-82. doi: 10.3109/02699052.2011.635360.

PMID:
22149446
8.

Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury.

Vos PE, Lamers KJ, Hendriks JC, van Haaren M, Beems T, Zimmerman C, van Geel W, de Reus H, Biert J, Verbeek MM.

Neurology. 2004 Apr 27;62(8):1303-10.

PMID:
15111666
9.

Modeling serum level of s100β and bispectral index to predict outcome after cardiac arrest.

Stammet P, Wagner DR, Gilson G, Devaux Y.

J Am Coll Cardiol. 2013 Aug 27;62(9):851-8. doi: 10.1016/j.jacc.2013.04.039. Epub 2013 May 15.

10.

Model predicting survival/exitus after traumatic brain injury: biomarker S100B 24h.

Gonzćlez-Mao MC, Repáraz-Andrade A, Del Campo-Pérez V, Alvarez-García E, Vara-Perez C, Andrade-Olivié MA.

Clin Lab. 2011;57(7-8):587-97.

PMID:
21888023
11.
12.

Early S-100B serum level correlates to quality of life in patients after severe head injury.

Woertgen C, Rothoerl RD, Brawanski A.

Brain Inj. 2002 Sep;16(9):807-16.

PMID:
12217206
13.

Serum adhesion molecules, outcome and neuro-psychological function in acute traumatic brain injury patients.

Wang HC, Wang PM, Lin YJ, Kwan AL, Lin WC, Tsai NW, Cheng BC, Chang WN, Su BY, Kung CT, Lu CH.

Clin Chim Acta. 2013 Aug 23;423:122-9. doi: 10.1016/j.cca.2013.04.023. Epub 2013 Apr 30.

PMID:
23643853
14.

Protein S-100b serum levels in trauma-induced brain death.

Dimopoulou I, Korfias S, Dafni U, Anthi A, Psachoulia C, Jullien G, Sakas DE, Roussos C.

Neurology. 2003 Mar 25;60(6):947-51.

PMID:
12654958
15.

A multiparameter panel method for outcome prediction following aneurysmal subarachnoid hemorrhage.

Turck N, Vutskits L, Sanchez-Pena P, Robin X, Hainard A, Gex-Fabry M, Fouda C, Bassem H, Mueller M, Lisacek F, Puybasset L, Sanchez JC.

Intensive Care Med. 2010 Jan;36(1):107-15. doi: 10.1007/s00134-009-1641-y. Epub 2009 Sep 17.

PMID:
19760205
16.

Long-term neurological and neuropsychological outcome in patients with severe traumatic brain injury.

Gautschi OP, Huser MC, Smoll NR, Maedler S, Bednarz S, von Hessling A, Lussmann R, Hildebrandt G, Seule MA.

Clin Neurol Neurosurg. 2013 Dec;115(12):2482-8. doi: 10.1016/j.clineuro.2013.09.038. Epub 2013 Oct 12.

PMID:
24184064
17.

Increased serum S100beta protein concentrations following severe head injury in humans: a biochemical marker of brain death?

Regner A, Kaufman M, Friedman G, Chemale I.

Neuroreport. 2001 Mar 26;12(4):691-4.

PMID:
11277565
18.

GFAP and S100B in the acute phase of mild traumatic brain injury.

Metting Z, Wilczak N, Rodiger LA, Schaaf JM, van der Naalt J.

Neurology. 2012 May 1;78(18):1428-33. doi: 10.1212/WNL.0b013e318253d5c7. Epub 2012 Apr 18.

PMID:
22517109
19.

The value of serum biomarkers in prediction models of outcome after mild traumatic brain injury.

Topolovec-Vranic J, Pollmann-Mudryj MA, Ouchterlony D, Klein D, Spence J, Romaschin A, Rhind S, Tien HC, Baker AJ.

J Trauma. 2011 Nov;71(5 Suppl 1):S478-86. doi: 10.1097/TA.0b013e318232fa70.

PMID:
22072007
20.

Association between injury indices and outcome after severe traumatic brain injury in children.

Massagli TL, Michaud LJ, Rivara FP.

Arch Phys Med Rehabil. 1996 Feb;77(2):125-32.

PMID:
8607735

Supplemental Content

Support Center